Alliance Pharma Share Price | |
---|---|
Price | 42.55 |
Bid | 42.50 |
Ask | 42.70 |
Change | -0.95 (-2.18%) |
Volume | 1,634,049 |
Open | 43.50 |
High | 43.55 |
Low | 42.55 |
Prev. Close | 43.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.57m |
Market Capitalisation | £230.01m |
Market Size | 20,000 |
52 Week High | 46.00 |
52 Week High Date | 22-Feb-2024 |
52 Week Low | 24.55 |
52 Week Low Date | 08-May-2024 |
# Trades | 155 |
---|---|
Vol. Sold | 664,313 |
Sold Value | £286.67k |
Vol. Bought | 969,736 |
Bought Value | £419.15k |
PE Ratio | -6.941272 |
Earnings | -6.13 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
04-Oct-24 | 16:35:00 | 42.55 | 59,979 | Buy* | 42.50 | 42.70 | 25.52k | UT Uncrossing Trade |
04-Oct-24 | 16:30:04 | 42.624 | 13,526 | Sell* | 44.55 | 40.85 | 5,765 | O Ordinary |
04-Oct-24 | 16:24:52 | 42.55 | 5,900 | Sell* | 42.45 | 42.95 | 2,510 | A Automatic Execution |
04-Oct-24 | 16:24:52 | 42.60 | 6,120 | Sell* | 42.60 | 43.00 | 2,607 | A Automatic Execution |
04-Oct-24 | 16:24:52 | 42.60 | 553 | Sell* | 42.60 | 43.00 | 235.58 | A Automatic Execution |
04-Oct-24 | 16:24:15 | 42.3719 | 52,356 | Sell* | 42.60 | 43.00 | 22.18k | O Ordinary |
04-Oct-24 | 16:15:40 | 43.00 | 472 | Buy* | 42.60 | 43.00 | 202.96 | A Automatic Execution |
04-Oct-24 | 16:15:40 | 43.00 | 3,387 | Sell* | 42.60 | 43.45 | 1,456 | A Automatic Execution |
04-Oct-24 | 16:15:40 | 43.00 | 8,400 | Buy* | 42.60 | 43.45 | 3,612 | A Automatic Execution |
04-Oct-24 | 16:15:40 | 43.00 | 8,721 | Buy* | 42.60 | 43.00 | 3,750 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions
Free Investment Tools
Register for FREE